Interestingly, a combination of anti-CD40 agonist and inhibition of CSF-1R induced macrophage pro-inflammatory phenotype prior CSF-1R mediated elimination, which was sufficient to reinvigorate CD8+ T cell response in transplanted tumours that were either resistant or sensitive to ICBs [111]. The gene discussed is CD8A; the disease is neoplasm.